Healthcare >> CEO Interviews >> November 1, 2002

Frederic Price – Biomarin Pharmaceutical Inc (bmrn)

FREDRIC PRICE was elected Chairman of the Board and Chief Executive Officer of BioMarin Pharmaceutical Inc. on October 31, 2000. From September 1994 to September 2000 he was President, Chief Executive Officer, and a member of the Board of Directors of Applied Microbiology/AMBI, a biotechnology and nutrition company. From July 1991 to September 1994, he was Vice President, Finance and Administration and Chief Financial Officer of Regeneron Pharmaceuticals. From March 1986 to July 1991, he was a pharmaceuticals and biotechnology industry strategy consultant. For the 13 previous years, he was employed by Pfizer Pharmaceuticals where he was a Vice President with both staff and line responsibilities. Mr. Price received a BA in 1967 from Dartmouth College and an MBA in 1969 from the Wharton School of the University of Pennsylvania. He is also a member of the Board of Directors of LifeSpan BioSciences, Inc., a biotechnology company based in Seattle, Washington. Profile
TWST: Could you give us a brief overview of what BioMarin

Pharmaceutical does?

Mr. Price: BioMarin Pharmaceutical is a biotech company that

focuses exclusively on enzyme therapeutics for